Rate and Predictors of Blood Pressure Control in a Federal Qualified Health Center in Michigan: A Huge Concern?

Journal of Clinical Hypertension

Volumn 15, Issue 4, 2013, Pages 254-263

  Olomu, Adesuwa B ^a,b   Gourineni, Venu ^a,b   Huang, Jason L ^c   Pandya, Nirzari ^a   Efeovbokhan, Nephertiti ^b   Samaraweera, Janaki ^a   Parashar, Kamesh ^a   Holmes Rovner, Margaret ^b  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; ARTICLE; BLOOD PRESSURE REGULATION; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; FEMALE; HEALTH DISPARITY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SECONDARY PREVENTION; SEX DIFFERENCE; UNITED STATES;

ADULT; AMBULATORY CARE FACILITIES; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; COMORBIDITY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; FEMALE; FINANCING, GOVERNMENT; HUMANS; HYPERTENSION; LOGISTIC MODELS; MALE; MEDICALLY UNINSURED; MICHIGAN; MIDDLE AGED; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS;

EID: 84875870783     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/jch.12067     Document Type: Article

References (49)

1. Yoon PW, Gillespie CD, George MG, Wall HK. Control of hypertension among adults - national health and nutrition examination survey, United States, 2005-2008. MMWR Morb Mortal Wkly Rep. 2012;61:19-25.
2. Centers for Disease Control (CDC). Vital signs: prevalence, treatment, and control of hypertension - United States, 1999-2002 and 2005-2008. MMWR Morb Mortal Wkly Rep. 2011;60:103-108.
3. Wang JT, Vasan RS. Epidemiology of uncontrolled hypertension in the United States. Circulation. 2005;112:1651-1662.
4. Lloyd-Jones DM, Evans JC, Larson MG, et al. Differential control of systolic and diastolic blood pressure: factors associated with lack of blood pressure control in the community. Hypertension. 2000;36:594-599.
5. Egan BM, Zhao Y, Axon RN. US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. JAMA. 2010;303:2043-2050.
6. Shelley D, Tseng TY, Andrews H, et al. Predictors of blood pressure control among hypertensive in community health centers. Am J Hypertens. 2011;24:1318-1323.
7. Egan BM, Basile JN. Controlling blood pressure in 50% of all hypertensive patients. J Investig Med. 2003;51:373-385.
8. US Department of Health and Human Services. Healthy People 2010. Understanding and Improving Health, 2nd ed. Washington, DC: US Government Printing Office; November 2000.
9. Mensah GA, Mokdad AH, Ford ES, et al. State of disparities in cardiovascular health in the United States. Circulation. 2005;111:1233-1241.
10. Wei M, Mitchell BD, Haffner SM, Stern MP. Effects of cigarette smoking, diabetes, high cholesterol, and hypertension on all-cause mortality and cardiovascular disease mortality in Mexican Americans. The San Antonio Heart Study. Am J Epidemiol. 1996;144:1058-1065.
11. Fiscella K, Holt K. Racial disparity in hypertension control: tallying the death toll. Ann Fam Med. 2008;6:497-502.
12. Thomas AJ, Eberly LE, Smith GD, et al. Race/ethnicity, income, major risk factors, and cardiovascular disease mortality. Am J Public Health. 2005;95:1417-1423.
13. Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics - 2012 update: a report from the American Heart Association. Circulation. 2012;125:e2-e220.
14. Wong MD, Shapiro MF, Boscardin WJ, Ettner SL. Contribution of major diseases to disparities in mortality. N Engl J Med. 2002;347:1585-1592.
15. Darnell JS. Free clinics in the United States: a nationwide survey. Arch Intern Med. 2010;170:946-953.
16. US Department of Health and Human Services, Health Resources and Services Administration, Bureau of Primary Health Care. Health Centers: America's Primary Care Safety Net, Reflections on Success, 2002-2007. Rockville, MD; June 2008.
17. Quality Incentives for Federally Qualified Health Centers, Rural Health Clinics and Free Clinics: A Report to Congress. Washington, DC: Department of Health Policy School of Public Health and Health Service; 2012.
18. Dievler A, Giovannini T. Community health centers: promise and performance. Med Care Res Rev. 1998;55:405-431.
19. Politzer RM, Yoon J, Shi L, et al. Inequality in America: the contribution of health centers in reducing and eliminating disparities in access to care. Med Care Res Rev. 2001;58:234-248.
20. Gale J, Coburn A. The Characteristics and Roles of Rural Health Clinics in the United States: A Chartbook. Portland, ME: University of Southern Maine, Muskie School of Public Service, Maine Rural Health Research Center; 2003.
21. Centers for Disease Control and Prevention. National Diabetes Fact Sheet: National Estimates and General Information on Diabetes and Prediabetes in the United States, 2011. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 2011.
22. Rabi DM, Edwards AL, Southern DA, et al. Association of socio-economic status with diabetes prevalence and utilization of diabetes care services. BMC Health Serv Res. 2006;6:124-130.
23. Agardh E, Allebeck P, Hallqvist J, et al. Type 2 diabetes incidence and socio-economic position: a systematic review and meta-analysis. Int J Epidemiol. 2011;40:804-818.
24. Duggirala MK, Cuddihy RM, Cuddihy MT, et al. Predictors of blood pressure control in patients with diabetes and hypertension seen in primary care clinics. Am J Hypertens. 2005;18:833-838.
25. Borzecki AM, Wong AT, Hickey EC, et al. Hypertension control: how well are we doing? Arch Intern Med. 2003;163:2705-2711.
26. Ferrannini E, Cushman WC. Diabetes and hypertension: the bad companions. Lancet. 2012;380:601-610.
27. Chen G, McAlister FA, Walker RL, et al. Cardiovascular outcomes in Framingham participants with diabetes: the importance of blood pressure. Hypertension. 2011;57:891-897.
28. 2010 Annual Report: Ingham County Health Department. http://hd.ingham.org/Portals/HD/Home/Documents/Publications/2010%20Annual%20Report%20Web%20Version.pdf. Accessed July 18, 2012.
29. Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC-7 report. JAMA. 2003;289:2560-2572.
30. SAS Institute Inc. Base SAS 9.2 Procedures Guide. Cary, NC; 2009.
31. Ornstein SM, Nietert PJ, Dickerson LM. Hypertension management and control in primary care: a study of 20 practices in 14 states. Pharmacotherapy. 2004;24:500-507.
32. DeVore AD, Sorrentino M, Arnsdorf MF, et al. Predictors of hypertension control in a diverse general cardiology practice. J Clin Hypertens (Greenwich). Aug 2010;12:570-577.
33. Cushman WC, Ford CE, Cutler JA, et al. Success and predictors of blood pressure control in diverse North American settings: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). J Clin Hypertens. 2002;4:393-404.
34. Olomu A, Gourineni V, Pandya N, et al. Office-Guidelines Applied in Practice (Office-GAP) Program in a federally qualified health center increased patient knowledge and medication use. Circulation. 2011;124:A12338.
35. Hicks L, Shaykevich S, Bates D, Ayanian J. Determinants of racial/ethnic differences in blood pressure management among hypertensive patients. BMC Cardiovasc Disord. 2005;5:16.
36. Hyman DJ, Pavlik VN. Characteristics of patients with uncontrolled hypertension in the United States. N Engl J Med. 2001;345:479-486.
37. Hicks LS, Fairchild DG, Horng MS, et al. Determinants of JNC VI guideline adherence, intensity of drug therapy, and blood pressure control by race and ethnicity. Hypertension. 2004;44:429-434.
38. Ong KL, Tso AW, Lam KS, Cheung BM. Gender difference in blood pressure control and cardiovascular risk factors in Americans with diagnosed hypertension. Hypertension. 2008;51:1142-1148.
39. Ahluwalia JS, McNagny SE, Rask KJ. Correlates of controlled hypertension in indigent, inner-city hypertensive patients. J Gen Intern Med. 1997;12:7-14.
40. Stockwell DH, Madhavan S, Cohen H, et al. The determinants of hypertension awareness, treatment, and control in an insured population. Am J Public Health. 1994;84:1768-1774.
41. Majernick TG, Zacker C, Madden NA, et al. Correlates of hypertension control in a primary care setting. Am J Hypertens. 2004;17:915-920.
42. Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA. 2003;290:199-206.
43. Reckelhoff JF. Gender differences in the regulation of blood pressure. Hypertension. 2001;37:1199-1208.
44. Bosworth HB, Dudley T, Olsen MK, et al. Racial differences in blood pressure control: potential explanatory factors. Am J Med. 2006;119:70.e9-70.e15.
45. Poirier P, Giles TD, Bray GA, et al. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and heart disease from the Obesity Committee of the Council on Nutrition, Physical activity, and Metabolism. Circulation. 2006;113:898-918.
46. Halperin RO, Gaziano JM, Sesso HD. Smoking and the risk of incident hypertension in middle-aged and older men. Am J Hypertens. 2008;21:148-152.
47. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators. Lancet. 2000;355:253-259.
48. Eurich DT, Majumdar SR, Tsuyuki RT, Johnson JA. Reduced mortality associated with the use of ACE inhibitors in patients with type 2 diabetes. Diabetes Care. 2004;27:1330-1334.
49. Barron HV, Michaels AD, Maynard C, et al. Use of antiotensin-converting enzyme inhibitors at discharge in patients with acute myocardial infarction in the United States: data from the National Registry of Myocardial Infarction 2. J Am Coll Cardiol. 1998;32:360-367.